- Report
- February 2024
- 70 Pages
Philippines
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 150 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 70 Pages
New Zealand
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 80 Pages
Europe
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 70 Pages
Russia
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 70 Pages
Germany
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 110 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 70 Pages
France
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 70 Pages
South Korea
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 120 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 143 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 70 Pages
New Zealand
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 100 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 85 Pages
North America
From €4533EUR$4,750USD£3,798GBP
- Report
- August 2023
- 90 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- August 2023
- 150 Pages
North America
From €4533EUR$4,750USD£3,798GBP
- Report
- April 2023
- 110 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- October 2022
- 70 Pages
Africa
From €4533EUR$4,750USD£3,798GBP
- Report
- August 2020
- 150 Pages
Global
From €4056EUR$4,250USD£3,398GBP
- Report
- December 2023
- 142 Pages
Brazil
From €2386EUR$2,500USD£1,999GBP

The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides.
Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more